Advertisement

Topics

Intersect ENT Inc. Company Profile

22:39 EDT 20th June 2018 | BioPortfolio

Intersect ENT Inc. (www.IntersectENT.com) is a medical device company that is pioneering novel therapies for Ear, Nose & Throat surgeons to utilize in providing improved treatment for their patients. Funding for Intersect has been provided by Kleiner, Perkins, Caufield & Byers; U.S. Venture Partners; and PTV Sciences. Intersect holds a strong intellectual property position in its core bioabsorbable drug delivery technology with four issued U.S. patents and over 50 US and foreign pending patent applications. Intersect and Intersect ENT are trademarks of Intersect.


News Articles [25 Associated News Articles listed on BioPortfolio]

Intersect ENT's steroid-releasing sinus implant debuted in US

Intersect ENT announced the US launch of its Sinuva steroid-releasing sinus implant, which is intended for the treatment of n -More- 

Intersect ENT to Present at William Blair & Company 38th Annual Growth Stock Conference

Intersect ENT, Inc. (Nasdaq: XENT) today announced that management will present at the 38th Annual William Blair Growth Stock Conference. The presentation is sched...

Intersect ENT to Present at the 7th Annual LEERINK Partners Global Healthcare Conference

Intersect ENT, Inc. (Nasdaq: XENT) today announced that management will be presenting at the 7th Annual LEERINK Partners Global Healthcare Conference on Wednesday, February 14, ...

Intersect ENT to Present at Deutsche Bank and Bank of America Merrill Lynch Conferences

Intersect ENT, Inc. (Nasdaq: XENT) today announced that management will present at Deutsche Bank’s 43rd Annual Health Care Conference and at Bank of America Merrill Lynch 2018 ...

Intersect ENT to Report First Quarter 2018 Financial Results

Intersect ENT, Inc. (NASDAQ:XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it will release financi...

Intersect ENT to Report Fourth Quarter and Year 2017 Financial Results

Intersect ENT, Inc. (NASDAQ: XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it will release financ...

Large Opportunities And High Expectations Battling It Out At Intersect ENT

Intersect ENT's (XENT) CEO Lisa Earnhardt on Q1 2018 Results - Earnings Call Transcript

Drugs and Medications [0 Results]

None

PubMed Articles [18 Associated PubMed Articles listed on BioPortfolio]

Integrating Mechanical Force into Lung Development.

In this issue of Developmental Cell, Tang et al. (2018) and Li et al. (2018) combine genetic manipulation, mechanical perturbation, and live imaging to show how mechanical forces and local growth fa...

Antigen presentation unfolded: identifying convergence points between the UPR and antigen presentation pathways.

The unfolded protein response (UPR) is an adaptive response meant to restore endoplasmic reticulum homeostasis in conditions of ER stress that subvert the folding capacity of the cell. Over the past f...

Calibrating a paracatadioptric camera by the property of the polar of a point at infinity with respect to a circle.

Two methods are presented for calibrating a paracatadioptric camera. A sphere in 3D space is projected to two parallel circles on which two tangents of a point and its antipode are parallel on the uni...

Temporospatial induction of homeodomain gene dictates natural lineage reprogramming.

Understanding how cellular identity naturally interconverts with high efficiency and temporospatial precision is crucial for regenerative medicine. Here we revealed a natural midgut-to-renal lineage c...

Aging and nutrition induce tissue-specific changes on global DNA methylation status in rats.

A number of epigenetic studies have demonstrated that DNA methylation patterns exhibit a tissue specificity, but not much has been done to highlight the extent of this phenomenon. Moreover, it is unkn...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Traditional Chinese Medicine for Treatment of Irritable Bowel Syndrome

Irritable bowel syndrome (IBS) is a prevalent condition that adversely affects patient's quality of life and represents a large health care burden globally. Currently, there is no satisfac...

Companies [4 Associated Companies listed on BioPortfolio]

Intersect ENT Inc.

Intersect ENT Inc. (www.IntersectENT.com) is a medical device company that is pioneering novel therapies for Ear, Nose & Throat surgeons to utilize in providing improved treatment for their patients. ...

Intersect ENT, Inc.

Intersect ENT Inc., located in Palo Alto, Calif., is an innovator in local drug delivery focused on advancing clinically proven therapy solutions that improve quality of life for ...

Intersect ENT, Inc. '

Intersect ENT, Inc. is dedicated to improving the quality of life for patients with ear, nose and throat conditions. The company markets two steroid releasing implants, PROPEL and...

EMBA Medical Limited

EMBA Medical™ Limited is a Dublin, Ireland, domiciled medical device company that designs and develops innovative peripheral embolization technologies focused on improving sa...

More Information about "Intersect ENT Inc." on BioPortfolio

We have published hundreds of Intersect ENT Inc. news stories on BioPortfolio along with dozens of Intersect ENT Inc. Clinical Trials and PubMed Articles about Intersect ENT Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Intersect ENT Inc. Companies in our database. You can also find out about relevant Intersect ENT Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record